Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation

Journal of Immunology

Volumn 165, Issue 7, 2000, Pages 4051-4061

  Wang, J ^a   Homer, R J ^a   Chen, Q ^a   Elias, J A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; METHACHOLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHILIA; INFLAMMATION; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY TRACT ALLERGY; TH2 CELL; TRANSGENIC MOUSE;

EID: 0034292488     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.7.4051     Document Type: Article

References (64)

1. Asthma: Epidemiology
2. An economic evaluation of asthma in the United States
3. + T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
4. Airway wall remodelling in the pathogenesis of asthma: Cytokine expression in the airways
5. Th2 cells and GATA-3 in asthma: New insights into the regulation of airway inflammation
6. Chronic inflammation in asthma
7. Chronicity and progression of asthma
8. Interleukin-6 in the lung
9. Rhinovirus stimulation of interleukin-6 in vivo and in vitro: Evidence for NF-κB-dependent transcriptional activation
10. Inflammatory determinants of asthma severity: Mediator and cellular changes in bronchoalveolar lavage fluid of patients with severe asthma
11. Role of IL-6 in the pleurisy and lung injury caused by carrageenan
12. Regulatory effects of interleukin-6 in immunoglobulin G immune-complex-induced lung injury
13. - T helper cell I development in interleukin 6-deficient mice infected with Candida albicans
14. Cytokine concentrations in the sputum of asthmatic patients
15. Interleukins-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines
16. Cytokines in symptomatic asthma airways
17. The role of interleukin-6 in mucosal IgA antibody responses in vivo
18. Defective inflammatory response in interleukin 6-deficient mice
19. Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased Lyme arthritis
20. Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice
21. Interleukin 6 plays a key role in the development of antigen-induced arthritis
22. Lethal tuberculosis in interleukin-6-deficient mutant mice
23. Impaired immune and acute-phase responses in interleukin-6-deficient mice
24. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
25. Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor β inhibit acute inflammation
26. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia
27. Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model
28. Overexpression of interleukin-6 in the central nervous system of transgenic mice increases central but not systemic proinflammatory cytokine production
29. Differential effects of IL-6 on systemic and central production of TNF: A study with IL-6-deficient mice
30. + T cells
31. Airway targeted interleukin-6 in transgenic mice: Uncoupling of airway inflammation and bronchial hyperreactivity
32. Airways hyperresponsiveness and airways obstruction in transgenic mice: Morphologic correlates in mice overexpressing IL-11 and IL-6
33. Essential role of nuclear factor kB in the induction of eosinophilia in allergic airway inflammation
34. Targeted lung expression of interleukin-11 enhances murine tolerance of 100% oxygen and diminishes hyperoxia-induced DNA fragmentation
35. Induction of airway mucus production by T helper 2 (Th2) cells: A critical role for interleukin 4 in cell recruitment but not mucus production
36. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiological abnormalities, and eotaxin production
37. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography
38. The expanding universe of T-cell subsets: Th1, Th2 and more
39. Anti-sclerotic effect of transforming growth factor-β antibody in a mouse model of bleomycin-induced scleroderma
40. TGF-β contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice
41. 1, a strong costimulator of rat T-cell activation promoting a shift towards a Th2-like cytokine profile
42. + T cell intrinsic mechanism
43. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells
44. Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA)
45. Interleukin-6 as an antiinflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble TNF receptor p55
46. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells
47. 2 alters antigen-presenting abilities of macrophages on T cell activation
48. Chemokines and asthma: Redundancy of function or a coordinated effort?
49. The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
50. Eotaxin triggers eosinophil selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin-5 in mice
51. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice
52. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts
53. Occupational asthma
54. Transforming growth factor-β regulation of IL-6 production by unstimulated and IL-1-stimulated human fibroblasts
55. Interleukin-6 inhibits transforming growth factor-β induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways
56. 1 and TNT-α on basal and IL-6-induced lipoprotein (a) and apolipoprotein (a) mRNA expression in primary monkey hepatocyte cultures
57. 2, interleukin 6 and fibronectin on corneal epithelial wound healing
58. Transforming growth factor-β enhances and pro-inflammatory cytokines inhibit ob gene expression in 3T3-L1 adipocytes
59. Effects of recombinant human transforming growth factor-β 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells
60. Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network
61. Tumor-associated transforming growth factor-β and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients
62. Interleukin-6 and transforming growth factor-β regulate the expression of monocyte chemoattractant protein-1 and colony-stimulating factors in human thyroid follicular cells
63. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma
64. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury